tiprankstipranks

Greg Madison Insider Profile

4 Followers
Greg Madison, Chief Executive Officer at Keryx Biopharma, holds 566.59K shares in Keryx Biopharma (Ticker: KERX), holds 1.89M shares in Shield Therapeutics (Ticker: GB:STX). Most recently, Greg Madison ― shares of Keryx Biopharma on ― for an estimated value of ―.
tipranks
Greg  Madison

Greg Madison
Keryx Biopharma (KERX)
Chief Executive Officer

Ranked #45,489 out of 97,944 Corporate Insiders

Profitable Transactions

100%
2 out of 2 Profitable Transactions

Average Return

+4.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

£42K
100.00%
A breakdown of Greg Madison's holdings

Insider Roles

Shield Therapeutics
(STX)
Chief Executive Officer
Roles that Greg Madison holds in companies

Most Profitable Insider Trade

Stock:
Shield Therapeutics
(STX)
Rating:Informative Sell
Date:Dec 28, 2022 - Dec 28, 2023
Return:+6.30%
The most profitable trade made by Greg Madison

Greg Madison's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KERX
Keryx Biopharma
$1.90M
Shield Therapeutics
Dec 28, 2022
Chief Executive Officer
Informative Sell
31.71K
£33.13K
List of latest transactions for each holding click on a transaction to see Greg Madison's performance on stock

Greg Madison insider profile FAQ

What is the percentage of profitable transactions made by Greg Madison?
The percentage of profitable transactions made by Greg Madison is 100%.
    What is the average return per transaction made by Greg Madison?
    The average return per transaction made by Greg Madison is 4.90%.
      What stocks does Greg Madison hold?
      Greg Madison holds: KERX, GB:STX stocks.
        What was Greg Madison’s latest transaction?
        Greg Madison latest transaction was an Uninformative Buy of ―.
          What was Greg Madison's most profitable transaction?
          Greg Madison’s most profitable transaction was an Informative Sell of GB:STX stock on December 28, 2022. The return on the trade was 6.30%.
            What is Greg Madison's role in Keryx Biopharma?
            Greg Madison's role in Keryx Biopharma is Chief Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.